Utah Medical Products, Inc. (UTMD)
| Market Cap | 181.27M |
| Revenue (ttm) | 39.27M |
| Net Income (ttm) | 12.96M |
| Shares Out | 3.28M |
| EPS (ttm) | 3.78 |
| PE Ratio | 14.37 |
| Forward PE | n/a |
| Dividend | $1.22 (2.21%) |
| Ex-Dividend Date | Jun 16, 2025 |
| Volume | 10,512 |
| Open | 55.25 |
| Previous Close | 54.37 |
| Day's Range | 55.25 - 55.25 |
| 52-Week Range | 51.26 - 77.33 |
| Beta | 0.30 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Apr 29, 2025 |
About UTMD
Utah Medical Products, Inc. provides medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. The company also provides GESCO, an umbilical vessel catheter, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percuta... [Read more]
Financial Performance
In 2024, Utah Medical Products's revenue was $40.90 million, a decrease of -18.56% compared to the previous year's $50.22 million. Earnings were $13.87 million, a decrease of -16.60%.
Financial StatementsNews
Utah Medical Products, Inc. Announces Quarterly Dividend
SALT LAKE CITY, UT / ACCESS Newswire / May 6, 2025 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty and one-half cents ($....
Stock Picks From Seeking Alpha's April 2025 New Analysts
In April, Seeking Alpha welcomed 20 new analysts. This article introduces them and showcases some of their top picks. Top picks include Palantir, Arch Capital Group, and Utah Medical Products, emphasi...
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2025
SALT LAKE CITY, UT / ACCESS Newswire / April 29, 2025 / In the first calendar quarter (1Q) of 2025, Utah Medical Products, Inc. (Nasdaq:UTMD) attained financial results consistent with its previously ...
Utah Medical Products: Quietly Profitable--A Deep Value Gem Hiding In The Open
Utah Medical Products develops and manufactures medical devices focused on women's health, obstetrics, gynecology, and blood pressure monitoring. The company's stock price has declined due to a drop i...
UTMD Reports Year 2024 and Fourth Quarter Financial Performance
SALT LAKE CITY, UT / ACCESS Newswire / January 28, 2025 / With Revenues 19% lower, Net Income 17% lower and Earnings Per Share (EPS) 13% lower than in 2023, Utah Medical Products, Inc. (NASDAQ:UTMD) c...
Utah Medical Products: Favorably Skewed Risk/Reward Profile
UTMD has been punished in 2024 despite high-quality business fundamentals and attractive valuation metrics. UTMD's economic characteristics are strong, with high post-tax margins and returns on capita...
Utah Medical Products, Inc. Appoints Director and Increases Quarterly Dividend
SALT LAKE CITY, UT / ACCESSWIRE / November 5, 2024 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors has appointed Carrie Leigh to its Board of Directors. Ms. Leigh, wh...
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2024
SALT LAKE CITY, UT / ACCESSWIRE / October 29, 2024 / Utah Medical Products, Inc. (NASDAQ:UTMD) reports third quarter (3Q) and first nine months (9M) of calendar year 2024 financial results that were w...
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2024
SALT LAKE CITY, UT / ACCESSWIRE / July 25, 2024 / As previously projected, Utah Medical Products, Inc. (Nasdaq:UTMD) realized second calendar quarter (2Q) and first half (1H) 2024 financial results wh...
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2024
SALT LAKE CITY, UT / ACCESSWIRE / April 25, 2024 / In the first calendar quarter (1Q) of 2024, Utah Medical Products, Inc. (NASDAQ:UTMD) attained financial results consistent with its previously annou...
UTMD Reports Audited Year 2023 and Fourth Quarter Financial Performance
SALT LAKE CITY, UT, Jan. 30, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – With Revenues 4% lower and Net Income and Earnings Per Share 1% higher than in 2022, Utah Medical Products, Inc. (Nasdaq: UTMD)...
Utah Medical Products, Inc. Increases Regular Quarterly Dividend
SALT LAKE CITY, UT / ACCESSWIRE / October 31, 2023 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of thirty cents ($.30) per share...
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2023
SALT LAKE CITY, UT, Oct. 26, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Utah Medical Products, Inc. [Nasdaq: UTMD], despite a difficult third calendar quarter (3Q), achieved financial results for nin...
Utah Medical Products: Long-Term Positives, But Filshie Clip Overhang Can't Be Ignored
Utah Medical Products stock has dropped 14% and is at its lowest point this year due to ongoing lawsuits regarding its Filshie clip system. The lawsuits do pose a risk to UTMD's stock price, and a neg...
UTMD Updates Status of Filshie Product Liability Lawsuits in the U.S.
SALT LAKE CITY, UT / ACCESSWIRE / August 31, 2023 / As Utah Medical Products, Inc.'s (NASDAQ:UTMD's) stockholders know, the following disclosure was included in the Company's 2022 SEC 10-K annual repo...
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2023
SALT LAKE CITY, UT, July 25, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Utah Medical Products, Inc. [Nasdaq: UTMD] achieved second calendar quarter (2Q) and first half (1H) 2023 financial results con...
Utah Medical Products: Earnings Power, Asset Factors Warrant Further Re-Rating
Utah Medical Products comes with high returns on capital and projected earnings growth into FY'25. The company has compounded earnings at a rate of 2.8x that of revenue since 2021. Net-net, reiterate ...
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2023
SALT LAKE CITY, UT, April 25, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - In the first calendar quarter (1Q) of 2023, Utah Medical Products, Inc. (Nasdaq: UTMD) attained financial results consistent w...
Utah Medical Products: Recycling Capital Well, Long-Term Gains On The Table
Utah Medical Products: Recycling Capital Well, Long-Term Gains On The Table
UTMD Reports Audited Year 2022 and Fourth Quarter Financial Performance
SALT LAKE CITY, UT, Jan. 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Utah Medical Products, Inc. (Nasdaq: UTMD) finished the calendar year with a solid fourth quarter (4Q) performance, which allow...
Is Utah Medical Products Suitable As A Defensive Overlay In Equity Portfolios?
UTMD is a relatively undercovered, unexploited name that historically trades within a narrow trading range, within a defensive sector. With this in mind, we wanted to see how it fits in within a cross...
UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2022
SALT LAKE CITY, UT, Oct. 25, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire - In the third calendar quarter (3Q) of 2022, despite significant cost inflation, supply chain disruption, litigation expenses an...
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2022
SALT LAKE CITY, UT , July 26, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire --UTMD achieved second calendar quarter (2Q) and first half (1H) 2022 financial results better than those anticipated in its beg...
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2022
SALT LAKE CITY, UT, April 26, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – In the first calendar quarter (1Q) of 2022, Utah Medical Products, Inc. (Nasdaq: UTMD) attained financial results consistent w...
UTMD Reports Audited Year 2021 and Fourth Quarter Financial Performance
Salt Lake City, Utah, Feb. 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- The fourth calendar quarter (4Q) of 2021 financial results demonstrate Utah Medical Products, Inc.'s (Nasdaq: UTMD's) contin...